Food and Drug Administration (FDA) evaluates investigational compounds through a structured review process that typically includes preclinical research, Phase 1, Phase 2, and Phase 3 clinical trials
In some embodiments, the lipid-based drug delivery formulation is a phospholipid-based formulation (e.g., hydrogenated or nonhydrogenated phospholipids, lecithins, phosphatidyl cholines (C8-C18), phosphatidylethanolamines (C8-C18), phosphatidylglycerols (C8-C18)) wherein the phospholipid is phospholipon 90H (1,2-dia-cyl-SN-glycero-3-phosphatidyl choline), egg phospholipids P123, Lipoid E80
In multi-omics detection, the combination of next-generation sequencing (NGS), polymerase chain reaction (PCR), and immunohistochemistry (IHC) provides powerful tools for investigating the mechanisms of HGSOC drug resistance
Cerebellar transcranial direct current stimulation (ctDCS): a novel approach to understanding cerebellar function in health and disease
Continue Reading The Best of Big D annual competition has voted Dr